Home > Insider Trading > Filing (0001209191-22-024531)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1658247	Crinetics Pharmaceuticals Inc.	CRNX	Pharmaceutical Preparations (2834)	263744114

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1746298	Scott Richard Struthers	C/O Crinetics Pharmaceuticals, Inc. 10222 Barnes Canyon Road, Bldg 2 San Diego CA 92121	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-04-13	24,674	$25.42	844,774	No	4	S	Indirect	By Family Trust 1
Common Stock	Disposition	2022-04-13	44,793	$26.52	799,981	No	4	S	Indirect	By Family Trust 1
Common Stock	Disposition	2022-04-13	69,176	$27.53	730,805	No	4	S	Indirect	By Family Trust 1

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Family Trust 1
No	4	S	Indirect	By Family Trust 1
No	4	S	Indirect	By Family Trust 1

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	57,400	Direct
Common Stock	1,000	Indirect	By Spouse
Common Stock	90,000	Indirect	By Family Trust 2
Common Stock	90,000	Indirect	By Family Trust 3
Common Stock	90,000	Indirect	By Family Trust 4

Footnotes

The sales reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date.
The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $25.4247 per share. The range of actual sales prices on the transaction date was $25.00 to $25.98 per share. Detailed information on the exact number of shares sold at each price can be obtained from the issuer upon request.
The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $26.5229 per share. The range of actual sales prices on the transaction date was $26.02 to $27.005 per share. Detailed information on the exact number of shares sold at each price can be obtained from the issuer upon request.
The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $27.5277 per share. The range of actual sales prices on the transaction date was $27.02 to $27.845 per share. Detailed information on the exact number of shares sold at each price can be obtained from the issuer upon request.